266 related articles for article (PubMed ID: 38318177)
41. An Erg-driven transcriptional program controls B cell lymphopoiesis.
Ng AP; Coughlan HD; Hediyeh-Zadeh S; Behrens K; Johanson TM; Low MSY; Bell CC; Gilan O; Chan YC; Kueh AJ; Boudier T; Feltham R; Gabrielyan A; DiRago L; Hyland CD; Ierino H; Mifsud S; Viney E; Willson T; Dawson MA; Allan RS; Herold MJ; Rogers K; Tarlinton DM; Smyth GK; Davis MJ; Nutt SL; Alexander WS
Nat Commun; 2020 Jun; 11(1):3013. PubMed ID: 32541654
[TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
[TBL] [Abstract][Full Text] [Related]
43. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R
Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719
[TBL] [Abstract][Full Text] [Related]
44. Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5.
Xu CR; Schaffer L; Head SR; Feeney AJ
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8685-90. PubMed ID: 18562282
[TBL] [Abstract][Full Text] [Related]
45. Wapl repression by Pax5 promotes V gene recombination by Igh loop extrusion.
Hill L; Ebert A; Jaritz M; Wutz G; Nagasaka K; Tagoh H; Kostanova-Poliakova D; Schindler K; Sun Q; Bönelt P; Fischer M; Peters JM; Busslinger M
Nature; 2020 Aug; 584(7819):142-147. PubMed ID: 32612238
[TBL] [Abstract][Full Text] [Related]
46. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes.
Linderson Y; Eberhard D; Malin S; Johansson A; Busslinger M; Pettersson S
EMBO Rep; 2004 Mar; 5(3):291-6. PubMed ID: 14993928
[TBL] [Abstract][Full Text] [Related]
47. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
[TBL] [Abstract][Full Text] [Related]
48. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
49. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells.
Ebert A; McManus S; Tagoh H; Medvedovic J; Salvagiotto G; Novatchkova M; Tamir I; Sommer A; Jaritz M; Busslinger M
Immunity; 2011 Feb; 34(2):175-87. PubMed ID: 21349430
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells.
Harris R; Randle S; Laman H
Biochem Biophys Res Commun; 2021 May; 554():41-48. PubMed ID: 33774278
[TBL] [Abstract][Full Text] [Related]
51. Identification of a candidate regulatory element within the 5' flanking region of the mouse Igh locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A.
Pawlitzky I; Angeles CV; Siegel AM; Stanton ML; Riblet R; Brodeur PH
J Immunol; 2006 Jun; 176(11):6839-51. PubMed ID: 16709844
[TBL] [Abstract][Full Text] [Related]
52. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
53. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.
Schick M; Habringer S; Nilsson JA; Keller U
Br J Haematol; 2017 Dec; 179(5):724-738. PubMed ID: 29171017
[TBL] [Abstract][Full Text] [Related]
54. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
[TBL] [Abstract][Full Text] [Related]
55. Spatial Regulation of V-(D)J Recombination at Antigen Receptor Loci.
Ebert A; Hill L; Busslinger M
Adv Immunol; 2015; 128():93-121. PubMed ID: 26477366
[TBL] [Abstract][Full Text] [Related]
56. Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas.
Geng LY; Shi ZZ; Dong Q; Cai XH; Zhang YM; Cao W; Peng JP; Fang YM; Zheng L; Zheng S
World J Gastroenterol; 2007 Apr; 13(16):2305-11. PubMed ID: 17511028
[TBL] [Abstract][Full Text] [Related]
57. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract][Full Text] [Related]
58. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
[TBL] [Abstract][Full Text] [Related]
59. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
60. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
